![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Neurones | EU:NRO | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.65 | 1.41% | 46.65 | 46.60 | 47.00 | 46.90 | 46.20 | 46.20 | 2,236 | 16:40:00 |
PRESS INFORMATION Nanterre, February 6, 2013 (after the closing of the stock exchange)
Heading: 2012 annual revenues
2012 annual revenues up 11.3% to €315.4 million
Revenues (millions of euros) | 2012 | 2011 | growth |
Annual | 315.4 | 283.3 | + 11.3% |
4th quarter | 84.6 | 76.4 | + 10.7% |
Achievements
For 2012, organic growth stands at + 9.3% in a consulting and IT services market that was expected to be stable in 2012.
In the 4th quarter, NEURONES' organic growth totaled + 8.3% (after + 11.0% in Q3, + 3.7% in Q2 and + 15% in Q1). This was the 35th consecutive quarter of organic growth.
Operating profit (*) in 2012 totaled 8.9% of revenues.
During the year, net cash and cash equivalents (no financial debt) increased from €75.1 to €87.8 million.
There were over 3,700 people on staff at the end of 2012.
The final annual results will be published on Wednesday, February 27, 2013 after the stock exchange closes.
(*) after 0.4% related to the cost of free shares, stock options and impairment of assets.
Outlook
As usual, forecasts for the coming year will be published along with the Group's 1st quarter revenues for 2013.
About NEURONES
With over 3,700 experts, the NEURONES group is specialized in Consulting (Management and Organization) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems. The size of the group has doubled over the past five years.
NYSE Euronext: Compartment B - ISIN code: FR0004050250 - NYSE symbol: NRO
www.neurones.net
Press Relations: Florence Gillier Communication Frédérique Guillo Tel.: +33 (0)1 41 18 85 55 fredg@fgcom.fr | NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 rp@neurones.net | Investor relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 investisseurs@neurones.net |
1 Year Neurones Chart |
1 Month Neurones Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions